Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trialAndrea Sartore‐Bianchi, Alberto Bardelli, Francesco Rua et al.|Nature Medicine|2022Cited by 259
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcriptionFrancesca Pagani, Pietro Luigi Poliani, Francesca Orzan et al.|Acta Neuropathologica|2025Cited by 6